<DOC>
	<DOC>NCT01306877</DOC>
	<brief_summary>The purpose of this study is to demonstrate that the Covidien EEAâ„¢ Hemorrhoid and Prolapse Stapling Set for the treatment of hemorrhoids is non-inferior to the competitor device based on the primary endpoint.</brief_summary>
	<brief_title>Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>The subject is able to understand and sign Informed Consent Form The subject is between 1885 years of age. The subject has (symptomatic) Grade 23 Hemorrhoids and is eligible for stapled hemorrhoidopexy The procedure is needed as revision hemorrhoid surgery. Any female patient, who is pregnant, suspected pregnant, or nursing. The participant has an active or a history of infection requiring antibiotics at the intended operative site within thirty (30) days prior to the planned surgery date. The participant is unable or unwilling to comply with the study requirements, followup schedule. The participant has a 1 year history of drug or alcohol abuse. The participant has a history of venous thrombosis or pulmonary embolism. The participant has a history of coagulopathy. The participant has taken aspirin, anticoagulation and/or anti platelet therapies (e.g. Warfarin, Lovenox) within 7 days prior to the planned date of surgery. The participant has a history of fecal incontinence The participant has had injection therapy, infrared laser treatment or rubber band ligation for treatment of hemorrhoids within 1 month of screening The participant has comorbidities which, in the opinion of the investigator, will not be appropriate for the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>hemorrhoid</keyword>
	<keyword>hemorrhoid stapler</keyword>
</DOC>